Skip to main content
Article
Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis.
Shock (2005)
  • Andreas Oberholzer, University of Florida
  • Caroline Oberholzer, University of Florida
  • Philip A. Efron, University of Florida
  • Philip O. Scumpia, University of Florida
  • Takefumi Uchida, University of Florida
  • Keith Bahjat, University of Florida
  • Ricardo Ungaro, University of Florida
  • Cynthia L. Tannahill, University of Florida
  • Michelle Murday, University of Florida
  • Frances R. Bahjat, Molecular Microbiology & Immunology
  • Van Tsai, Merck & Co.
  • Beth Hutchins, Merck & Co.
  • Lyle L. Moldawer, University of Florida
  • Drake Laface, Merck & Co.
  • Michael J. Clare-Salzler, University of Florida
Publication Date
June 1, 2005
DOI
10.1097/01.SHK.0000163208.29655.74
Citation Information
Andreas Oberholzer, Caroline Oberholzer, Philip A. Efron, Philip O. Scumpia, et al.. "Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis." Shock Vol. 23 Iss. 6 (2005) p. 507 - 515
Available at: http://works.bepress.com/michelle-murday/4/